&#35; Peter Kolchinsky

"Will The Virus Win?" with virologist Peter Kolchinsky

Uncomfortable Conversations with Josh Szeps

LS 56

TOP 0.5%

2 अगस्त 2020 · अनुलिपि

Peter Kolchinsky is a scientist and biotechnology investor, with a deep understanding of how viruses outsmart us. His company, RA Capital Management, builds and invests in biotech companies. Hosted on Acast. See acast.com/privacy for more information.

01:54:04

Where's the Promise of Biotech? Featuring Peter Kolchinsky

FEG Insight Bridge

LS 23

TOP 10%

5 अगस्त 2025

In this episode of FEG’s Insight Bridge Podcast, Greg Dowling speaks with Peter Kolchinsky, Managing Partner at RA Capital. Together they delve into the drivers and details of today’s biotech industry, how to foster innovation and why Peter is optimistic about biotech’s ability to address autoimmun…

00:39:04

Best-of Edition: Peter Kolchinsky & John LaMattina on the IRA

Vital Health Podcast

LS 25

TOP 10%

6 अगस्त 2025

In this “Best of” edition, host Duane Schulthess revisits two landmark conversations on the long-term impact of the Inflation Reduction Act (IRA) on the biopharmaceutical industry. First, Peter Kolchinsky (Managing Partner, RA Capital Management; Steering Committee Member, No Patient Left Behind), …

00:59:07

Two leaders from the Harvard Biotech Club talk about their experience in the club, its new podcast, The Pulse, and an upcoming career fair on September 19th

The Studio at Kendall Square

2 सितमबर 2025

Yossef Baidi and Fang Xie describe how getting involved in the club has benefited them, and the idea behind their new podcast (George Church and Peter Kolchinsky have already been guests). Plus, the September 19th career fair that traditionally draws 1,000 attendees and so far already has 17 compan…

00:16:48

Ep. 103 - Kolchinsky: FDA Conservatism, MFN and IRA Are Slowing Drug Development

The BioCentury Show

✓

LS 27

TOP 10%

18 फ़रवरी 2026

Caution: This episode of The BioCentury Show contains strong language.In a candid interview with BioCentury, RA Capital Managing Partner Peter Kolchinsky warns that staffing losses and growing conservatism at FDA are slowing drug development and pushing companies to launch early-stage trials outsid…

00:40:58

Making Value Propositions Clearer with Peter Kolchinsky, PhD, Founder and Managing Partner, RA Capital Management

Perspectives by the Leerink Center for Pharmacoeconomics

2 मार्च 2026

Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, talks with Peter Kolchinsky, PhD, Founder and Managing Partner of RA Capital Management, to discuss if the U.S. market-based approach to pricing novel prescription medicines could result in paying more than they are worth a…

00:45:29

Live from Boston: Investor math versus industrial priority

Post-Hoc Live

7 अगस्त 2026

Should investors embrace China’s fast-moving, fast-growing biotech sector, or should there be barriers to protect and preserve an industry that the US has dominated for decades? Ginkgo Bioworks CEO Jason Kelly, RA Capital Management's Peter Kolchinsky, and MIT professor Fiona Murray debate all side…

00:45:10